Marta Banaszkiewicz
Overview
Explore the profile of Marta Banaszkiewicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kurzyna P, Witowicz A, Kedzierski P, Florczyk M, Banaszkiewicz M, Szwed P, et al.
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941569
Several studies describe the sex-specific differences in cardiovascular diseases. However, there is still limited research reporting the difference between men and women with chronic thromboembolic pulmonary hypertension (CTEPH) treated with...
2.
Urbanowicz T, Gabriel K, Spasenenko I, Krasinska-Plachta A, Banaszkiewicz M, Filipiak K, et al.
Postepy Kardiol Interwencyjnej
. 2025 Feb;
20(4):413-419.
PMID: 39897017
Introduction: Morbidity related to cardiovascular disease (CVD) is a leading epidemiological problem. Carotid intima-media thickness (CIMT) can be regarded as a surrogate marker for cardiovascular disease. Lipid-lowering agents such as...
3.
Urbanowicz T, Spasenenko I, Banaszkiewicz M, Krasinska-Plachta A, Krasinski Z, Krasinska B
Pol Arch Intern Med
. 2025 Jan;
135(1).
PMID: 39868580
No abstract available.
4.
Kedzierski P, Banaszkiewicz M, Florczyk M, Pilka M, Manczak R, Wieteska-Milek M, et al.
Biomedicines
. 2025 Jan;
13(1.
PMID: 39857754
: Treprostinil, which is administered via continuous subcutaneous or intravenous infusion, is a medication applied in the treatment of pulmonary arterial hypertension (PAH). The dose of treprostinil is adjusted on...
5.
Banaszkiewicz M, Pietrasik A, Darocha S, Pilka M, Florczyk M, Dobosiewicz A, et al.
Arch Med Sci
. 2024 Dec;
20(5):1442-1451.
PMID: 39649252
Introduction: Non-invasive tests that may improve clinical evaluation of pulmonary hypertension (PH) are needed. The purpose of this study was to assess the role of soluble ST2 (sST2) in patients...
6.
Urbanowicz T, Spasenenko I, Banaszkiewicz M, Olasinska-Wisniewska A, Krasinska-Plachta A, Tykarski A, et al.
Diagnostics (Basel)
. 2024 Nov;
14(22).
PMID: 39594245
Background: An increasing number of heart failure with preserved ejection fraction (HFpEF) syndromes has been reported in tandem with increasing age and burdens of obesity and cardiometabolic disorders. Identifying possible...
7.
Kurzyna P, Banaszkiewicz M, Florczyk M, Kepski J, Pilka M, Kedzierski P, et al.
Cancers (Basel)
. 2024 Apr;
16(8).
PMID: 38672644
The risk of venous thromboembolism (VTE) in the oncology population is significantly higher than in non-cancer patients. Inferior vena cava (IVC) filters may, therefore, be an important part of VTE...
8.
Pilka M, Darocha S, Florczyk M, Manczak R, Banaszkiewicz M, Kedzierski P, et al.
J Clin Med
. 2023 Dec;
12(24).
PMID: 38137690
Background: The ECG-PH index (PH-ECG score) has been proposed as a valuable ECG-derived method of evaluating the effectiveness of balloon pulmonary angioplasty (BPA) in chronic thromboembolic pulmonary hypertension (CTEPH). Pulmonary...
9.
Banaszkiewicz M, Kurzyna P, Kubikowska N, Mucha M, Rudnik A, Gasecka A, et al.
J Clin Med
. 2023 Aug;
12(16).
PMID: 37629379
In this article, we discuss the topic of chronic thromboembolic pulmonary disease (CTEPD) and the growing role of balloon pulmonary angioplasty (BPA) in its treatment. We present the pathophysiology of...
10.
Olejnik A, Krzywonos-Zawadzka A, Banaszkiewicz M, Bil-Lula I
Int J Mol Sci
. 2022 Dec;
23(24).
PMID: 36555091
Ischaemia, followed by reperfusion, causes the generation of reactive oxygen species, overproduction of peroxynitrite, activation of matrix metalloproteinases (MMPs), and subsequently the degradation of heart contractile proteins in the cardiomyocytes....